Zentiva (BSE:SCD) Interest Received

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BSE:SCD Zentiva SA BSE:SCD
10 GF Score
Price lei4.52
View Full Analysis

What is Zentiva Interest Received?

Interest Received only applicable to companies reporting Cash Flow from Operations in direct method.

BSE:SCD
10GF Score
Zentiva SA BSE:SCD
Interest Received is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Zentiva Business Description

Address No. 50, Theodor Pallady Boulevard, Sector 3, Bucharest, ROU, 032266
Zentiva SA is a Romania-based producer of medicines on the local market. The product portfolio of Zentiva SA includes more than 126 products for human use, such as solids (tablets, capsules, and pellets), generic products, and injectable solutions. The company provides products for therapeutic areas such as Cardiovascular diseases, Anti-inflammatory and pain-relieving medications, urologists, Blood diseases, Gastrointestinal and metabolic disorders, Central nervous system, Medicines against infections, and Diseases of the respiratory system.
10GF Score

Get the complete analysis for BSE:SCD

Interest Received is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

lei4.52
Price